InvestorsHub Logo
Followers 438
Posts 18533
Boards Moderated 0
Alias Born 09/10/2000

Re: None

Thursday, 12/29/2022 7:37:46 AM

Thursday, December 29, 2022 7:37:46 AM

Post# of 240
Calithera continued to advance multiple vacuolar protein sorting-associated protein 4A (VPS4A) and VPS4B inhibitors through lead optimization and plans to share updates on this program by the end of 2022.

Disclaimer:
I call them the way I see them, if you disagree then the truth is hidden somewhere, and the truth will never be hidden for very long.